ALDH7A1 Gene Pyridoxine-Dependent Epilepsy Genetic Test sale cost 4400 AED
SLC25A4 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 2 Autosomal Dominant Genetic Test sale cost 4400 AED SLC25A4 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 2 Autosomal Dominant Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
SACS Gene Spastic Ataxia Charlevoix-Saguenay Type Genetic Test sale cost 4400 AED SACS Gene Spastic Ataxia Charlevoix-Saguenay Type Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

ALDH7A1 Gene Pyridoxine-Dependent Epilepsy Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ALDH7A1 gene pyridoxine-dependent epilepsy genetic test is a specialized diagnostic tool used to identify mutations in the ALDH7A1 gene, which are associated with pyridoxine-dependent epilepsy (PDE). PDE is a rare, genetic disorder characterized by seizures that are not controllable with usual antiepileptic drugs but can be effectively managed with daily doses of pyridoxine (vitamin B6). Early diagnosis and treatment are crucial to prevent neurological damage and improve patient outcomes.

This genetic test is conducted by extracting DNA from a blood sample and analyzing the ALDH7A1 gene for specific mutations known to cause PDE. The process involves sophisticated laboratory techniques to ensure accurate detection of genetic abnormalities.

The cost of the ALDH7A1 gene pyridoxine-dependent epilepsy genetic test is 4400 AED. The test is available at DNA Labs UAE, a reputable laboratory known for its advanced genetic testing services. DNA Labs UAE employs state-of-the-art technology and adheres to stringent quality control measures to provide reliable and precise test results, making it a trusted choice for patients and healthcare providers seeking genetic testing for pyridoxine-dependent epilepsy.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ALDH7A1 Gene Pyridoxine-dependent epilepsy Genetic Test

Welcome to DNA Labs UAE, where we offer the ALDH7A1 Gene Pyridoxine-dependent epilepsy Genetic Test. This test is designed to detect mutations or variations in the ALDH7A1 gene associated with pyridoxine-dependent epilepsy (PDE), also known as antiquitin deficiency.

Test Components

The ALDH7A1 Gene Pyridoxine-dependent epilepsy Genetic Test includes the following components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

The test results will be delivered within 3 to 4 weeks.

Method

The ALDH7A1 Gene Pyridoxine-dependent epilepsy Genetic Test utilizes NGS (Next-Generation Sequencing) technology.

Test Type

This test is specifically designed for the diagnosis of neurological disorders.

Doctor

The test is conducted by a neurologist.

Test Department

The ALDH7A1 Gene Pyridoxine-dependent epilepsy Genetic Test is conducted in our Genetics department.

Pre Test Information

Prior to undergoing the ALDH7A1 Gene Pyridoxine-dependent epilepsy Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by ALDH7A1 Gene Pyridoxine-dependent epilepsy.

Test Details

The ALDH7A1 gene is associated with pyridoxine-dependent epilepsy (PDE), a rare genetic disorder that affects the brain’s ability to metabolize pyridoxine, a derivative of vitamin B6. Individuals with PDE experience seizures that do not respond to traditional anti-seizure medications but can be effectively managed with high doses of pyridoxine.

NGS genetic testing is used to analyze multiple genes simultaneously, allowing for the identification of genetic variations or mutations associated with specific conditions. In the case of PDE, NGS genetic testing can detect mutations or variations in the ALDH7A1 gene, helping to confirm a diagnosis and provide valuable information for healthcare providers.

The ALDH7A1 Gene Pyridoxine-dependent epilepsy Genetic Test is not only useful for confirming a diagnosis in individuals with suspected symptoms but also for carrier testing in individuals with a family history of the condition. This information can assist healthcare providers in determining the most appropriate treatment and management strategies for individuals with PDE.

Test Name ALDH7A1 Gene Pyridoxine-dependent epilepsy Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ALDH7A1 Gene Pyridoxine-dependent epilepsy NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ALDH7A1 Gene Pyridoxine-dependent epilepsy
Test Details

The ALDH7A1 gene is associated with pyridoxine-dependent epilepsy (PDE), also known as antiquitin deficiency. PDE is a rare genetic disorder that affects the brain’s ability to metabolize the vitamin B6 derivative, pyridoxine. This leads to seizures that are unresponsive to traditional anti-seizure medications but can be effectively managed with high doses of pyridoxine.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the identification of genetic variations or mutations that may be responsible for a particular condition. In the case of PDE, NGS genetic testing can be used to detect mutations or variations in the ALDH7A1 gene that are associated with the disorder.

This type of genetic testing can help confirm a diagnosis of PDE in individuals with suspected symptoms and can also be used for carrier testing in individuals with a family history of the condition. It can provide valuable information for healthcare providers to determine the most appropriate treatment and management strategies for individuals with PDE.

SKU: TEST-1952 Category:

Related products